Stephen Maxted Ansell, MD, PhD

  • 22799 Citations
  • 81 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling

Hildebrand, J. M., Luo, Z., Manske, M. K., Price-Troska, T., Ziesmer, S. C., Lin, W., Hostager, B. S., Slager, S. L., Witzig, T. E., Ansell, S. M., Cerhan, J. R., Bishop, G. A. & Novak, A. J., Nov 22 2010, In : Journal of Experimental Medicine. 207, 12, p. 2569-2579 11 p.

Research output: Contribution to journalArticle

60 Scopus citations

Absolute lymphocyte count predicts overall survival in follicular lymphomas

Siddiqui, M., Ristow, K., Markovic, S. N., Witzig, T. E., Habermann, T. M., Colgan, J. P., Inwards, D. J., White, W. L., Ansell, S. M., Micallef, I. N., Johnston, P. B., Call, T. G. & Porrata, L. F., Sep 1 2006, In : British journal of haematology. 134, 6, p. 596-601 6 p.

Research output: Contribution to journalArticle

83 Scopus citations

Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas

Behl, D., Ristow, K., Markovic, S. N., Witzig, T. E., Habermann, T. M., Colgan, J. P., Inwards, D. J., White, W. L., Ansell, S. M., Micallef, I. N., Johnston, P. B. & Porrata, L. F., Jun 1 2007, In : British journal of haematology. 137, 5, p. 409-415 7 p.

Research output: Contribution to journalArticle

49 Scopus citations
41 Scopus citations

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

Dispenzieri, A., Lacy, M. Q., Katzmann, J. A., Rajkumar, S. V., Abraham, R. S., Hayman, S. R., Kumar, S. K., Clark, R., Kyle, R. A., Litzow, M. R., Inwards, D. J., Ansell, S. M., Micallef, I. M., Porrata, L. F., Elliott, M. A., Johnston, P. B., Greipp, P. R., Witzig, T. E., Zeldenrust, S. R., Russell, S. J. & 2 others, Gastineau, D. & Gertz, M. A., Apr 15 2006, In : Blood. 107, 8, p. 3378-3383 6 p.

Research output: Contribution to journalArticle

197 Scopus citations

Acalabrutinib in mantle cell lymphoma

Kapoor, P. & Ansell, S. M., Jan 1 2017, (Accepted/In press) In : The Lancet.

Research output: Contribution to journalArticle

3 Scopus citations

Accuracy of self-reported tobacco use status among hematopoietic SCT patients

Ehlers, S. L., Bronars, C. A., Patten, C. A., Brockman, T., Hughes, C., Decker, P. A., Cerhan, J. R., Hogan, W., Dispenzieri, A., Ansell, S., Ebbert, J. & Gastineau, D., Jul 2014, In : Bone Marrow Transplantation. 49, 7, p. 961-965 5 p.

Research output: Contribution to journalArticle

4 Scopus citations

Activation of TAK1 by MYD88 L265P drives malignant B-cell growth in non-Hodgkin lymphoma

Ansell, S. M., Hodge, L. S., Secreto, F. J., Manske, M., Braggio, E., Price-Troska, T., Ziesmer, S., Li, Y., Johnson, S. H., Hart, S. N., Kocher, J. P. A., Vasmatzis, G., Chanan-Kahn, A., Gertz, M., Fonseca, R., Dogan, A., Cerhan, J. R. & Novak, A. J., Feb 2014, In : Blood cancer journal. 4, 2, 20144.

Research output: Contribution to journalArticle

50 Scopus citations
7 Scopus citations

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Huet, S., Tesson, B., Jais, J. P., Feldman, A. L., Magnano, L., Thomas, E., Traverse-Glehen, A., Albaud, B., Carrère, M., Xerri, L., Ansell, S. M., Baseggio, L., Reyes, C., Tarte, K., Boyault, S., Haioun, C., Link, B. K., Feugier, P., Lopez-Guillermo, A., Tilly, H. & 10 others, Brice, P., Hayette, S., Jardin, F., Offner, F., Sujobert, P., Gentien, D., Viari, A., Campo, E., Cerhan, J. R. & Salles, G., Apr 2018, In : The Lancet Oncology. 19, 4, p. 549-561 13 p.

Research output: Contribution to journalArticle

48 Scopus citations

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

Vijai, J., Wang, Z., Berndt, S. I., Skibola, C. F., Slager, S. L., De Sanjose, S., Melbye, M., Glimelius, B., Bracci, P. M., Conde, L., Birmann, B. M., Wang, S. S., Brooks-Wilson, A. R., Lan, Q., De Bakker, P. I. W., Vermeulen, R. C. H., Portlock, C., Ansell, S. M., Link, B. K., Riby, J. & 82 others, North, K. E., Gu, J., Hjalgrim, H., Cozen, W., Becker, N., Teras, L. R., Spinelli, J. J., Turner, J., Zhang, Y., Purdue, M. P., Giles, G. G., Kelly, R. S., Zeleniuch-Jacquotte, A., Ennas, M. G., Monnereau, A., Bertrand, K. A., Albanes, D., Lightfoot, T., Yeager, M., Chung, C. C., Burdett, L., Hutchinson, A., Lawrence, C., Montalvan, R., Liang, L., Huang, J., Ma, B., Villano, D. J., Maria, A., Corines, M., Thomas, T., Novak, A. J., Dogan, A., Liebow, M., Thompson, C. A., Witzig, T. E., Habermann, T. M., Weiner, G. J., Smith, M. T., Holly, E. A., Jackson, R. D., Tinker, L. F., Ye, Y., Adami, H. O., Smedby, K. E., De Roos, A. J., Hartge, P., Morton, L. M., Severson, R. K., Benavente, Y., Boffetta, P., Brennan, P., Foretova, L., Maynadie, M., McKay, J., Staines, A., DIver, W. R., Vajdic, C. M., Armstrong, B. K., Kricker, A., Zheng, T., Holford, T. R., Severi, G., Vineis, P., Ferri, G. M., Ricco, R., Miligi, L., Clavel, J., Giovannucci, E., Kraft, P., Virtamo, J., Smith, A., Kane, E., Roman, E., Chiu, B. C. H., Fraumeni, J. F., Wu, X., Cerhan, J. R., Offit, K., Chanock, S. J., Rothman, N. & Nieters, A., Jan 8 2015, In : Nature communications. 6, 6751.

Research output: Contribution to journalArticle

30 Scopus citations

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Parrilla Castellar, E. R., Jaffe, E. S., Said, J. W., Swerdlow, S. H., Ketterling, R. P., Knudson, R. A., Sidhu, J. S., Hsi, E. D., Karikehalli, S., Jiang, L., Vasmatzis, G., Gibson, S. E., Ondrejka, S., Nicolae, A., Grogg, K. L., Allmer, C., Ristow, K. M., Wilson, W. H., Macon, W. R., Law, M. E. & 6 others, Cerhan, J. R., Habermann, T. M., Ansell, S. M., Dogan, A., Maurer, M. J. & Feldman, A. L., Aug 28 2014, In : Blood. 124, 9, p. 1473-1480 8 p., 1284.

Research output: Contribution to journalArticle

183 Scopus citations

AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantion in non-Hodgkin lymphoma

Holtan, S. G., Porrata, L. F., Micallef, I. N. M., Padley, D. J., Inwards, D. J., Ansell, S. A., Johnston, P. B., Gastineau, D. A. & Markovic, S. N., Jan 2007, In : Clinical Lymphoma and Myeloma. 7, 4, p. 315-318 4 p.

Research output: Contribution to journalArticle

44 Scopus citations

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Cozen, W., Timofeeva, M. N., Li, D., Diepstra, A., Hazelett, D., Delahaye-Sourdeix, M., Edlund, C. K., Franke, L., Rostgaard, K., Van Den Berg, D. J., Cortessis, V. K., Smedby, K. E., Glaser, S. L., Westra, H. J., Robison, L. L., Mack, T. M., Ghesquieres, H., Hwang, A. E., Nieters, A., De Sanjose, S. & 47 others, Lightfoot, T., Becker, N., Maynadie, M., Foretova, L., Roman, E., Benavente, Y., Rand, K. A., Nathwani, B. N., Glimelius, B., Staines, A., Boffetta, P., Link, B. K., Kiemeney, L., Ansell, S. M., Bhatia, S., Strong, L. C., Galan, P., Vatten, L., Habermann, T. M., Duell, E. J., Lake, A., Veenstra, R. N., Visser, L., Liu, Y., Urayama, K. Y., Montgomery, D., Gaborieau, V., Weiss, L. M., Byrnes, G., Lathrop, M., Cocco, P., Best, T., Skol, A. D., Adami, H. O., Melbye, M., Cerhan, J. R., Gallagher, A., Taylor, G. M., Slager, S. L., Brennan, P., Coetzee, G. A., Conti, D. V., Onel, K., Jarrett, R. F., Hjalgrim, H., Van Den Berg, A. & McKay, J. D., Jun 12 2014, In : Nature communications. 5, 3856.

Research output: Contribution to journalArticle

46 Scopus citations

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

Sampson, J. N., Wheeler, W. A., Yeager, M., Panagiotou, O., Wang, Z., Berndt, S. I., Lan, Q., Abnet, C. C., Amundadottir, L. T., Figueroa, J. D., Landi, M. T., Mirabello, L., Savage, S. A., Taylor, P. R., De Vivo, I., McGlynn, K. A., Purdue, M. P., Rajaraman, P., Adami, H. O., Ahlbom, A. & 388 others, Albanes, D., Amary, M. F., An, S. J., Andersson, U., Andriole, G., Andrulis, I. L., Angelucci, E., Ansell, S. M., Arici, C., Armstrong, B. K., Arslan, A. A., Austin, M. A., Baris, D., Barkauskas, D. A., Bassig, B. A., Becker, N., Benavente, Y., Benhamou, S., Berg, C., Van Den Berg, D., Bernstein, L., Bertrand, K. A., Birmann, B. M., Black, A., Boeing, H., Boffetta, P., Boutron-Ruault, M. C., Bracci, P. M., Brinton, L., Brooks-Wilson, A. R., Bueno-De-Mesquita, H. B., Burdett, L., Buring, J., Butler, M. A., Cai, Q., Cancel-Tassin, G., Canzian, F., Carrato, A., Carreon, T., Carta, A., Chan, J. K. C., Chang, E. T., Chang, G. C., Chang, I. S., Chang, J., Chang-Claude, J., Chen, C. J., Chen, C. Y., Chen, C., Chen, C. H., Chen, C., Chen, H., Chen, K., Chen, K. Y., Chen, K. C., Chen, Y., Chen, Y. H., Chen, Y. S., Chen, Y. M., Chien, L. H., Chirlaque, M. D., Choi, J. E., Choi, Y. Y., Chow, W. H., Chung, C. C., Clavel, J., Clavel-Chapelon, F., Cocco, P., Colt, J. S., Comperat, E., Conde, L., Connors, J. M., Conti, D., Cortessis, V. K., Cotterchio, M., Cozen, W., Crouch, S., Crous-Bou, M., Cussenot, O., Davis, F. G., Ding, T., Diver, W. R., Dorronsoro, M., Dossus, L., Duell, E. J., Ennas, M. G., Erickson, R. L., Feychting, M., Flanagan, A. M., Foretova, L., Fraumeni, J. F., Freedman, N. D., Freeman, L. E. B., Fuchs, C., Gago-Dominguez, M., Gallinger, S., Gao, Y. T., Gapstur, S. M., Garcia-Closas, M., García-Closas, R., Gascoyne, R. D., Gastier-Foster, J., Gaudet, M. M., Gaziano, J. M., Giffen, C., Giles, G. G., Giovannucci, E., Glimelius, B., Goggins, M., Gokgoz, N., Goldstein, A. M., Gorlick, R., Gross, M., Grubb, R., Gu, J., Guan, P., Gunter, M., Guo, H., Habermann, T. M., Haiman, C. A., Halai, D., Hallmans, G., Hassan, M., Hattinger, C., He, Q., He, X., Helzlsouer, K., Henderson, B., Henriksson, R., Hjalgrim, H., Hoffman-Bolton, J., Hohensee, C., Holford, T. R., Holly, E. A., Hong, Y. C., Hoover, R. N., Horn-Ross, P. L., Hosain, G. M. M., Hosgood, H. D., Hsiao, C. F., Hu, N., Hu, W., Hu, Z., Huang, M. S., Huerta, J. M., Hung, J. Y., Hutchinson, A., Inskip, P. D., Jackson, R. D., Jacobs, E. J., Jenab, M., Jeon, H. S., Ji, B. T., Jin, G., Jin, L., Johansen, C., Johnson, A., Jung, Y. J., Kaaks, R., Kamineni, A., Kane, E., Kang, C. H., Karagas, M. R., Kelly, R. S., Khaw, K. T., Kim, C., Kim, H. N., Kim, J. H., Kim, J. S., Kim, Y. H., Kim, Y. T., Kim, Y. C., Kitahara, C. M., Klein, A. P., Klein, R. J., Kogevinas, M., Kohno, T., Kolonel, L. N., Kooperberg, C., Kricker, A., Krogh, V., Kunitoh, H., Kurtz, R. C., Kweon, S. S., La Croix, A., Lawrence, C., Lecanda, F., Lee, V. H. F., Li, D., Li, H., Li, J., Li, Y. J., Li, Y., Liao, L. M., Liebow, M., Lightfoot, T., Lim, W. Y., Lin, C. C., Lin, D., Lindstrom, S., Linet, M. S., Link, B. K., Liu, C., Liu, J., Liu, L., Ljungberg, B., Lloreta, J., Di Lollo, S., Lu, D., Lund, E., Malats, N., Mannisto, S., Marchand, L. L., Marina, N., Masala, G., Mastrangelo, G., Matsuo, K., Maynadie, M., McKay, J., McKean-Cowdin, R., Melbye, M., Melin, B. S., Michaud, D. S., Mitsudomi, T., Monnereau, A., Montalvan, R., Moore, L. E., Mortensen, L. M., Nieters, A., North, K. E., Novak, A. J., Oberg, A. L., Offit, K., Oh, I. J., Olson, S. H., Palli, D., Pao, W., Park, I. K., Park, J. Y., Park, K. H., Patiño-Garcia, A., Pavanello, S., Peeters, P. H. M., Perng, R. P., Peters, U., Petersen, G. M., Picci, P., Pike, M. C., Porru, S., Prescott, J., Prokunina-Olsson, L., Qian, B., Qiao, Y. L., Rais, M., Riboli, E., Riby, J., Risch, H. A., Rizzato, C., Rodabough, R., Roman, E., Roupret, M., Ruder, A. M., De Sanjose, S., Scelo, G., Schned, A., Schumacher, F., Schwartz, K., Schwenn, M., Scotlandi, K., Seow, A., Serra, C., Serra, M., Sesso, H. D., Setiawan, V. W., Severi, G., Severson, R. K., Shanafelt, T. D., Shen, H., Shen, W., Shin, M. H., Shiraishi, K., Shu, X. O., Siddiq, A., Sierrasesúmaga, L., Sihoe, A. D. L., Skibola, C. F., Smith, A., Smith, M. T., Southey, M. C., Spinelli, J. J., Staines, A., Stampfer, M., Stern, M. C., Stevens, V. L., Stolzenberg-Solomon, R. S., Su, J., Su, W. C., Sund, M., Sung, J. S., Sung, S. W., Tan, W., Tang, W., Tardón, A., Thomas, D., Thompson, C. A., Tinker, L. F., Tirabosco, R., Tjønneland, A., Travis, R. C., Trichopoulos, D., Tsai, F. Y., Tsai, Y. H., Tucker, M., Turner, J., Vajdic, C. M., Vermeulen, R. C. H., Villano, D. J., Vineis, P., Virtamo, J., Visvanathan, K., Wactawski-Wende, J., Wang, C., Wang, C. L., Wang, J. C., Wang, J., Wei, F., Weiderpass, E., Weiner, G. J., Weinstein, S., Wentzensen, N., White, E., Witzig, T. E., Wolpin, B. M., Wong, M. P., Wu, C., Wu, G., Wu, J., Wu, T., Wu, W., Wu, X., Wu, Y. L., Wunder, J. S., Xiang, Y. B., Xu, J., Xu, P., Yang, P. C., Yang, T. Y., Ye, Y., Yin, Z., Yokota, J., Yoon, H. I., Yu, C. J., Yu, H., Yu, K., Yuan, J. M., Zelenetz, A., Zeleniuch-Jacquotte, A., Zhang, X. C., Zhang, Y., Zhao, X., Zhao, Z., Zheng, H., Zheng, T., Zheng, W., Zhou, B., Zhu, M., Zucca, M., Boca, S. M., Cerhan, J. R., Ferri, G. M., Hartge, P., Hsiung, C. A., Magnani, C., Miligi, L., Morton, L. M., Smedby, K. E., Teras, L. R., Vijai, J., Wang, S. S., Brennan, P., Caporaso, N. E., Hunter, D. J., Kraft, P., Rothman, N., Silverman, D. T., Slager, S. L., Chanock, S. J. & Chatterjee, N., Jan 1 2015, In : Journal of the National Cancer Institute. 107, 12

Research output: Contribution to journalArticle

70 Scopus citations
4 Scopus citations

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

1 Scopus citations

An RNA aptamer-based biomarker platform demonstrates high soluble cd25 occupancy by il2 in the serum of follicular lymphoma patients

Veeramani, S., Blackwell, S. E., Thiel, W. H., Yang, Z. Z., Ansell, S. M., Giangrande, P. H. & Weiner, G. J., Jan 1 2019, In : Cancer Immunology Research. 7, 9, p. 1511-1522 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Antilymphoma treatments given subsequent to yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: A review of the literature

Ansell, S. M., Schilder, R. J., Pieslor, P. C., Gordon, L. I., Emmanouilides, C., Vo, K., Czuczman, M. S., Witzig, T. E., Theuer, C. & Molina, A., Dec 2004, In : Clinical Lymphoma. 5, 3, p. 202-204 3 p.

Research output: Contribution to journalArticle

41 Scopus citations

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma

Younes, A., Vose, J. M., Zelenetz, A. D., Smith, M. R., Burris, H. A., Ansell, S. M., Klein, J., Halpern, W., Miceli, R., Kumm, E., Fox, N. L. & Czuczman, M. S., Dec 7 2010, In : British journal of cancer. 103, 12, p. 1783-1787 5 p.

Research output: Contribution to journalArticle

101 Scopus citations

A phase 1 study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Dispenzieri, A., Wiseman, G. A., Lacy, M. Q., Litzow, M. R., Anderson, P. M., Gastineau, D. A., Tefferi, A., Inwards, D. J., Micallef, I. N. M., Ansell, S. M., Porrata, L., Elliot, M. A., Lust, J. A., Greipp, P. R., Rajkumar, S. V., Fonseca, R., Witzig, T. E., Erlichman, C., Sloan, J. A. & Gertz, M. A., Jan 2005, In : Leukemia. 19, 1, p. 118-125 8 p.

Research output: Contribution to journalArticle

36 Scopus citations

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma

Dispenzieri, A., D'Souza, A., Gertz, M., Laumann, K., Wiseman, G., Lacy, M., LaPlant, B., Buadi, F., Hayman, S. R., Kumar, S. K., Dingli, D. M., Hogan, W., Ansell, S. M., Gastineau, D. A., Inwards, D. J., Micallef, I., Porrata, L. F., Johnston, P. B., Litzow, M. R. & Witzig, T. E., Oct 1 2017, In : Bone Marrow Transplantation. 52, 10, p. 1372-1377 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

5 Scopus citations

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

Larsen, J. T., Hogan, W. J., Micallef, I. N., Dispenzieri, A., Gertz, M. A., Inwards, D. J., Tun, H. W., Roy, V., Geyer, S. M., Allred, J. B., Wu, W., Ansell, S. M., Elliott, M. A., Tefferi, A., Porrata, L. F., Gastineau, D. A., Lacy, M. Q. & Litzow, M. R., Aug 1 2013, In : Leukemia and Lymphoma. 54, 8, p. 1713-1718 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

A phase II clinical study of suramin in combination with mitomycin C in patients with non small cell lung cancer

Rapoport, B. L., Falkson, G., Ansell, S. M., Lotz, B. P. & de Wet, M., Oct 1991, In : Lung Cancer. 7, 5, p. 323-328 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

A phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Dispenzieri, A., Wiseman, G. A., Lacy, M. Q., Hayman, S. R., Kumar, S. K., Buadi, F., Dingli, D., Laumann, K. M., Allred, J., Geyer, S. M., Litzow, M. R., Gastineau, D. A., Inwards, D. J., Micallef, I. N., Ansell, S. M., Porrata, L., Elliott, M. A., Johnston, P. B., Hogan, W. J. & Gertz, M. A., Jun 1 2010, In : American journal of hematology. 85, 6, p. 409-413 5 p.

Research output: Contribution to journalArticle

26 Scopus citations

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): Final results from the T- cell consortium trial

Advani, R. H., Ansell, S. M., Lechowicz, M. J., Beaven, A. W., Loberiza, F., Carson, K. R., Evens, A. M., Foss, F., Horwitz, S., Pro, B., Pinter-Brown, L. C., Smith, S. M., Shustov, A. R., Savage, K. J. & Vose, J. M., Feb 1 2016, In : British journal of haematology. 172, 4, p. 535-544 10 p.

Research output: Contribution to journalArticle

41 Scopus citations

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

De Vos, S., Forero-Torres, A., Ansell, S. M., Kahl, B., Cheson, B. D., Bartlett, N. L., Furman, R. R., Winter, J. N., Kaplan, H., Timmerman, J., Whiting, N. C., Drachman, J. G. & Advani, R., Jun 12 2014, In : Journal of Hematology and Oncology. 7, 1, 44.

Research output: Contribution to journalArticle

36 Scopus citations

A phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors

Ansell, S. M., Pitot, H. C., Burch, P. A., Kvols, L. K., Mahoney, M. R. & Rubin, J., Apr 15 2001, In : Cancer. 91, 8, p. 1543-1548 6 p.

Research output: Contribution to journalArticle

93 Scopus citations

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Witzig, T. E., Reeder, C. B., Laplant, B. R., Gupta, M., Johnston, P. B., Micallef, I. N., Porrata, L. F., Ansell, S. M., Colgan, J. P., Jacobsen, E. D., Ghobrial, I. M. & Habermann, T. M., Feb 2011, In : Leukemia. 25, 2, p. 341-347 7 p.

Research output: Contribution to journalArticle

240 Scopus citations

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Johnston, P. B., Inwards, D. J., Colgan, J. P., Laplant, B. R., Kabat, B. F., Habermann, T. M., Micallef, I. N., Porrata, L. F., Ansell, S. M., Reeder, C. B., Roy, V. & Witzig, T. E., May 1 2010, In : American journal of hematology. 85, 5, p. 320-324 5 p.

Research output: Contribution to journalArticle

175 Scopus citations

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma

Witzig, T. E., Wiseman, G. A., Maurer, M. J., Habermann, T. M., Micallef, I. N. M., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Link, B. K., Zent, C. S., Johnston, P. B., Shanafelt, T. D., Allmer, C., Asmann, Y. W., Gupta, M., Ballas, Z. K., Smith, B. J. & Weiner, G. J., Jul 1 2013, In : American journal of hematology. 88, 7, p. 589-593 5 p.

Research output: Contribution to journalArticle

19 Scopus citations

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma

Micallef, I. N. M., Kahl, B. S., Maurer, M. J., Dogan, A., Ansell, S. M., Colgan, J. P., Geyer, S., Inwards, D. J., White, W. L. & Habermann, T. M., Dec 15 2006, In : Cancer. 107, 12, p. 2826-2832 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma

Racila, E., Link, B. K., Weng, W. K., Witzig, T. E., Ansell, S., Maurer, M. J., Huang, J., Dahle, C., Halwani, A., Levy, R. & Werner, G. J., Oct 15 2008, In : Clinical Cancer Research. 14, 20, p. 6697-6703 7 p.

Research output: Contribution to journalArticle

113 Scopus citations
41 Scopus citations

A role for IFN-λ1 in multiple myeloma B cell growth

Novak, A. J., Grote, D. M., Ziesmer, S. C., Rajkumar, V., Doyle, S. E. & Ansell, S. M., Jan 1 2008, In : Leukemia. 22, 12, p. 2240-2246 7 p.

Research output: Contribution to journalArticle

16 Scopus citations

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy

Bachy, E., Maurer, M. J., Habermann, T. M., Gelas-Dore, B., Maucort-Boulch, D., Estell, J. A., Van den Neste, E., Bouabdallah, R., Gyan, E., Feldman, A. L., Bargay, J., Delmer, A., Slager, S. L., da Silva, M. G., Fitoussi, O., Belada, D., Maisonneuve, H., Intragumtornchai, T., Ansell, S. M., Lamy, T. & 5 others, Dartigues, P., Link, B. K., Seymour, J. F., Cerhan, J. R. & Salles, G., Jul 5 2018, In : Blood. 132, 1, p. 49-58 10 p.

Research output: Contribution to journalArticle

28 Scopus citations

Association between facility volume and mortality of patients with classic Hodgkin lymphoma

Goyal, G., Tella, S. H., Funni, S., Kommalapati, A., Inselman, J. W., Shah, N. D., Go, R. S. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

4 Scopus citations

AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia

Paulus, A., Chitta, K., Akhtar, S., Personett, D., Miller, K. C., Thompson, K. J., Carr, J., Kumar, S., Roy, V., Ansell, S. M., Mikhael, J. R., Dispenzieri, A., Reeder, C. B., Rivera, C. E., Foran, J. & Chanan-Khan, A., Feb 1 2014, In : British journal of haematology. 164, 3, p. 352-365 14 p.

Research output: Contribution to journalArticle

19 Scopus citations

Attenuation of CD8+ T-cell function by CD4+CD25 + regulatory T cells in B-cell non-Hodgkin's lymphoma

Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M., Oct 15 2006, In : Cancer research. 66, 20, p. 10145-10152 8 p.

Research output: Contribution to journalArticle

125 Scopus citations
17 Scopus citations

Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I. N., Johnston, P. B., Villasboas, J. C. & Markovic, S. N., Jun 2019, In : Leukemia Research. 81, p. 1-9 9 p.

Research output: Contribution to journalArticle

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: A status report

Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Hayman, S. R., Kumar, S. K., Dingli, D., Ansell, S. M., Gastineau, D. A., Inwards, D. J., Johnston, P. B., Litzow, M. R., Micallef, I. N. M., Porrata, L. F., Leung, N., Hogan, W. J. & Buadi, F. K., Dec 1 2010, In : Leukemia and Lymphoma. 51, 12, p. 2181-2187 7 p.

Research output: Contribution to journalArticle

78 Scopus citations

Autologous stem cell transplant in 716 patients with multiple myeloma: Low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative

Gertz, M. A., Ansell, S. M., Dingli, D., Dispenzieri, A., Buadi, F. K., Elliott, M. A., Gastineau, D. A., Hayman, S. R., Hogan, W. J., Inwards, D. J., Johnston, P. B., Kumar, S., Lacy, M. Q., Leung, N., Micallef, I. N. M., Porrata, L. F., Schafer, B. A., Wolf, R. C. & Litzow, M. R., Oct 2008, In : Mayo Clinic proceedings. 83, 10, p. 1131-1135 5 p.

Research output: Contribution to journalArticle

71 Scopus citations

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders

Wilcox, R. A., Feldman, A. L., Wada, D. A., Yang, Z. Z., Comfere, N. I., Dong, H., Kwon, E. D., Novak, A. J., Markovic, S. N., Pittelkow, M. R., Witzig, T. E. & Ansell, S. M., Nov 20 2009, In : Blood. 114, 10, p. 2149-2158 10 p.

Research output: Contribution to journalArticle

139 Scopus citations

B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells

Secreto, F., Manske, M., Price-Troska, T., Ziesmer, S., Hodge, L. S., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Aug 2014, In : Leukemia and Lymphoma. 55, 8, p. 1884-1892 9 p.

Research output: Contribution to journalArticle

5 Scopus citations

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

15 Scopus citations